Ascend Wellness Holdings (AAWH) Invested Capital (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Invested Capital came in at $246.7 million in Q1 2026, up 32064.41% year-on-year from N/an in Q1 2025, and little changed quarter-over-quarter from $246.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Invested Capital (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Invested Capital history runs 7 years deep, the most recent figure standing at $246.7 million for Q1 2026.
- On a quarterly basis, Invested Capital rose 32064.41% year-over-year to $246.7 million in Q1 2026; TTM through Mar 2026 was $882.5 million, a 9.24% decrease from a year earlier, with the FY2025 full-year figure at $246.7 million, down 25.08% from the prior year.
- Invested Capital held at $246.7 million in Q1 2026 per AAWH's latest filing, from $246.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $388.4 million in Q3 2025 and bottomed at $679000.0 in Q2 2025.
- The 5-year median for Invested Capital is $315.1 million (2023), against an average of $243.4 million.
- Across the five-year window, Invested Capital plunged 99.78% in 2025 and jumped 32064.41% in 2026, its largest moves.
- Year by year, Invested Capital stood at $341.0 million in 2022, then fell by 7.57% to $315.1 million in 2023, then grew by 4.5% to $329.3 million in 2024, then retreated by 25.08% to $246.7 million in 2025, then decreased by 0.01% to $246.7 million in 2026.
- Per Business Quant, the three latest AAWH Invested Capital figures stand at $246.7 million (Q1 2026), $246.7 million (Q4 2025), and $388.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 246.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.70 Mn |
| Dec 31, 2025 | 246.74 Mn |
| Sep 30, 2025 | 388.35 Mn |
| Jun 30, 2025 | 679,000.00 |
| Mar 31, 2025 | 767,000.00 |
| Dec 31, 2024 | 329.33 Mn |
| Sep 30, 2024 | 328.39 Mn |
| Jun 30, 2024 | 313.78 Mn |
| Mar 31, 2024 | 315.98 Mn |
| Dec 31, 2023 | 315.15 Mn |
| Sep 30, 2023 | 314.83 Mn |
| Jun 30, 2023 | 318.19 Mn |
| Mar 31, 2023 | 333.41 Mn |
| Dec 31, 2022 | 340.97 Mn |
| Sep 30, 2022 | 321.76 Mn |
| Jun 30, 2022 | 11.23 Mn |
| Mar 31, 2022 | 11.11 Mn |
| Dec 31, 2021 | 266.87 Mn |
| Sep 30, 2021 | 25.07 Mn |
| Jun 30, 2021 | 24.06 Mn |